Geron Stem Cell Trial Risky, Doctors Warn

March 12, 2009

Geron’s upcoming and widely publicized stem cell trial involving patients with spinal cord injuries was criticized as risky and clinically dubious because the entire rationale for the study is “based on a single experiment in eight rats.” (The Street)